SERA PROGNOSTICS, INC. Interest Expense
SERA PROGNOSTICS, INC. (SERA) reported Interest Expense of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-12
- SERA PROGNOSTICS, INC. interest expense for the quarter ending 2026-06-30 was $2.00K, a 0.00% change year-over-year.
- SERA PROGNOSTICS, INC. interest expense for the quarter ending 2026-03-31 was $2.00K, a 50.00% decline year-over-year.
- SERA PROGNOSTICS, INC. interest expense for the quarter ending 2025-12-31 was $1.00K, a 83.33% decline year-over-year.
- SERA PROGNOSTICS, INC. interest expense for the quarter ending 2025-09-30 was $2.00K, a 60.00% decline year-over-year.
- SERA PROGNOSTICS, INC. interest expense for fiscal 2025 was $9.00K, a 67.86% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. interest expense for fiscal 2024 was $28.00K, a 49.09% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. interest expense for fiscal 2023 was $55.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-12 | $4.00K 10-Q · filed 2026-08-12 | $5.00K derived: sum of 3 quarters · filed 2026-08-12 | $7.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-06 | $3.00K derived: sum of 2 quarters · filed 2026-05-06 | $5.00K derived: sum of 3 quarters · filed 2026-05-06 | $7.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $3.00K derived: sum of 2 quarters · filed 2026-03-18 | $5.00K derived: sum of 3 quarters · filed 2026-08-12 | $9.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-13 | $4.00K derived: sum of 2 quarters · filed 2026-08-12 | $8.00K 10-Q · filed 2025-11-13 | $14.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-12 | $6.00K 10-Q · filed 2026-08-12 | $12.00K derived: sum of 3 quarters · filed 2026-08-12 | $17.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-06 | $10.00K derived: sum of 2 quarters · filed 2026-05-06 | $15.00K derived: sum of 3 quarters · filed 2026-05-06 | $23.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $11.00K derived: sum of 2 quarters · filed 2026-03-18 | $19.00K derived: sum of 3 quarters · filed 2026-03-18 | $28.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $5.00K 10-Q · filed 2025-11-13 | $13.00K derived: sum of 2 quarters · filed 2025-11-13 | $22.00K 10-Q · filed 2025-11-13 | $33.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $8.00K 10-Q · filed 2025-08-06 | $17.00K 10-Q · filed 2025-08-06 | $28.00K derived: sum of 3 quarters · filed 2025-08-06 | $42.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-07 | $20.00K derived: sum of 2 quarters · filed 2025-05-07 | $34.00K derived: sum of 3 quarters · filed 2025-05-07 | $48.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $25.00K derived: sum of 2 quarters · filed 2025-03-19 | $39.00K derived: sum of 3 quarters · filed 2025-03-19 | $55.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $14.00K 10-Q · filed 2024-11-06 | $28.00K derived: sum of 2 quarters · filed 2024-11-06 | $44.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $14.00K 10-Q · filed 2024-08-07 | $30.00K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $16.00K 10-Q · filed 2024-05-08 | |||
| 2022-09-30 | $21.00K 10-Q · filed 2023-11-08 | $39.00K derived: sum of 2 quarters · filed 2023-11-08 | $43.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $18.00K 10-Q · filed 2023-08-09 | $22.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-10 | |||
| 2021-09-30 | $439.00K 10-Q · filed 2022-11-09 | $437.00K derived: sum of 2 quarters · filed 2022-11-09 | $744.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$2.00K 10-Q · filed 2022-08-10 | $305.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $307.00K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |